Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


McKesson Corp. stock underperforms Friday when compared to competitors

2025-09-12
McKesson Corp. stock underperforms Friday when compared to competitors

McKesson (MCK) Outperforms Broader Market: What You Need to Know

2025-09-11
The latest trading day saw McKesson (MCK) settling at $719.8, representing a +1.92% change from its previous close.

McKesson (MCK) Stock Is Up, What You Need To Know

2025-09-11
Shares of healthcare distributor and services company McKesson (NYSE:MCK) jumped 2.7% in the afternoon session after the company inked a deal with Walmart and USAntibiotics, the nation's only manufacturer of amoxicillin.

McKesson Corp. stock outperforms competitors on strong trading day

2025-09-11
McKesson Corp. stock outperforms competitors on strong trading day

Is Trending Stock McKesson Corporation (MCK) a Buy Now?

2025-09-11
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

Q2 Earnings Highs And Lows: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks

2025-09-11
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at McKesson (NYSE:MCK) and the best and worst performers in the healthcare providers & services industry.

Playhouse MD™ Launches on Amazon with McKesson Medical-Surgical Leading Distribution of First-Ever Playful Pediatric Devices

2025-09-09
Playhouse MD™, the new healthcare brand dedicated to reimagining pediatric care through the power of play, is now officially available on Amazon.

McKesson Corp. stock underperforms Monday when compared to competitors despite daily gains

2025-09-08
McKesson Corp. stock underperforms Monday when compared to competitors despite daily gains

USAntibiotics Working with Walmart and McKesson to Support U.S. Manufacturing of Amoxicillin

2025-09-08
BRISTOL, Tenn., September 08, 2025--USAntibiotics, the nation’s lone remaining manufacturer of amoxicillin and amoxicillin clavulanate, today announced a new collaboration with Walmart and McKesson through their joint venture partner ClarusONE Sourcing Services to provide domestically manufactured antibiotics made by USAntibiotics in the United States for millions of patients nationwide.

Docusign Announces Second Quarter Fiscal 2026 Financial Results

2025-09-04
Docusign, Inc. (NASDAQ: DOCU) today announced results for its fiscal quarter ended July 31, 2025. Prepared remarks and the news release with the financial results will be accessible on Docusign's website at investor.docusign.com prior to its webcast.